Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Notes Payables: 2013-2022

Historic Notes Payables for Fortress Biotech (FBIO) over the last 7 years, with Dec 2022 value amounting to $2.9 million.

  • Fortress Biotech's Notes Payables was N/A to $3.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2022, which is 263.05% up from last year.
  • According to the latest figures from FY2022, Fortress Biotech's Notes Payables is $2.9 million, which was up 263.05% from $812,000 recorded in FY2021.
  • Fortress Biotech's Notes Payables' 5-year high stood at $9.9 million during FY2018, with a 5-year trough of $812,000 in FY2021.
  • Over the past 2 years, Fortress Biotech's median Notes Payables value was $1.9 million (recorded in 2021), while the average stood at $1.9 million.
  • Its Notes Payables has fluctuated over the past 5 years, first plummeted by 84.14% in 2018, then skyrocketed by 263.05% in 2022.
  • Over the past 4 years, Fortress Biotech's Notes Payables (Yearly) stood at $9.9 million in 2018, then dropped by 27.17% to $7.2 million in 2019, then reached $812,000 in 2021, then skyrocketed by 263.05% to $2.9 million in 2022.